mDIXON Quant MRI Findings of Breast Myofibroblastoma

Creative Commons License

Ozgul H. A., BAŞARA AKIN I., ALTAY C., GÜRAY DURAK M., BALCI P.

CYPRUS JOURNAL OF MEDICAL SCIENCES, cilt.8, sa.3, ss.234-236, 2023 (ESCI) identifier identifier

  • Yayın Türü: Makale / Editöre Mektup
  • Cilt numarası: 8 Sayı: 3
  • Basım Tarihi: 2023
  • Doi Numarası: 10.4274/cjms.2020.2734
  • Dergi Adı: CYPRUS JOURNAL OF MEDICAL SCIENCES
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.234-236
  • Anahtar Kelimeler: Breast, myofibroblastoma, mDIXON quant, magnetic resonance imaging
  • Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

The mDIXON quant sequence is a chemical shift encoding based on the proton density fat fraction, which can assess fat content quantitatively. Myofibroblastoma (MFB) is a benign mesenchymal entity, and its prevalence is less than 1% of all breast tumors. Since MFB includes variable amounts of fat-containing fascicles, the mDIXON quant sequence provides a prominent contribution in evaluating fat content in the lesion.